Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... Keywords: City:Roskilde, Country:Denmark, Cyclooxygenase Inhibitor, Diclofenac, NSAID, Sciatica. This article was prepared by Biotech Business Week editors from ...
2009 NOV 16 ... concluded: "A reduction in H. pylori-related peptic ulcers, changing patterns in NSAID use and increasing PPI use may have contributed to a decline in uncomplicated peptic ...
2009 NOV 16 ... w/w. Pennsaid Topical Solution is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of the signs and symptoms of osteoarthritis of the knee. ...
2009 NOV 16 ... "Alabama between 2005 and 2007. 687 patients participating in the Alabama NSAID Patient Safety Study (age >= 50 years and currently taking a prescription ...
2009 NOV 23 ... adenoma risk compared with never smokers (OR = 1.40; 95% CI 1.16-1.84). Regular NSAID intake was associated with lower risk in subjects who reported their use at least twice ...
2009 NOV 23 ... explanation for observations in humans: retrospective studies indicate long-term NSAID use is protective against AD, whereas prospective NSAID ...
2009 NOV 23 ... 0.4% 4 times a day, bromfenac 0.09% 2 times a day, nepafenac 0.1% 3 times a day, or no NSAID for 3 days before surgery. Nonsteroidal antiinflammatory drugs and prostaglandin E-2 ...
2009 NOV 16 ... "Sulindac (SLD) is a nonsteroidal anti-inflammatory drug ( NSAID) that has been associated with a greater incidence of idiosyncratic hepatotoxicity in ...
2009 NOV 16 ... with proton pump inhibitor (PPI) therapy on nonsteroidal anti-inflammatory drug (NSAID) treatment duration and upper-gastrointestinal (GI) complications in patients with ...
2009 NOV 9 ... underlying mechanism, including involvement of the nonsteroidal anti-inflammatory drug (NSAID)-activated gene (NAG-1)." "Inhibition of cell proliferation, induction of ...
2009 NOV 9 ... as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The Company has decided to retain control of its aspirin ...
2009 NOV 16 ... at hospital discharge. We sought to assess understanding of risk factors for NSAID-related upper gastrointestinal (GI) complications among junior and senior residents, ...
2009 NOV 16 ... 1.118) for recovery defined as a pain score of 0 or 1. The interaction between sex and NSAID treatment was statistically significant (P = 0.044, hazard ratio = 1.755, 95% confidence ...
2009 NOV 16 ... injuries in patients treated with non-steroidal anti-inflammatory drugs (NSAID). Cobiprostone patients experienced an overall statistically significant reduction in ...
